Table 1 Basic characteristics of the included studies.

From: Decolonization strategies for ESBL-producing or carbapenem-resistant Enterobacterales carriage: a systematic review and meta-analysis

Study

Country

Study years

Number of patients/mean ± SD or median

Age (years)

Male/female (persons)

Study design

Targeted bacteria

Saidel-Odes et al. (2012)14

Israel

2008–2010

40/69.1

26/14

P, case–control/SC

KP, KA

Park et al. (2022)19

Korea

2019–2020

62/76.4 ± 8.5

40/22

R, cohort/SC

CRE

Bar-Yoseph et al. (2021)28

Israel

2018–2019

39/58.2

21/18

P, cohort/SC

CPE

Bilinski et al. (2017)31

Poland

2015–2016

20/51.0

16/4

P, cohort/SC

CRE

Battipaglia et al. (2019)32

Australia

2014–2017

10/48.0

4/6

R, cohort/SC

CPE

Pellicé (2021)20

Spain

2018–2019

73/62.4

40/33

P, cohort/SC

KPC-Kp

Seong (2020)33

Korea

2018–2020

16/NS

NS

P, cohort/SC

CPE

Dinh et al. (2018)34

France

2015–2017

8/73.0

5/3

P, cohort/MC

CRE

Huttner et al. (2013)15

Switzerland

2009–2012

58/54.5

34/24

P, case–control/SC

ESBL-E

Rieg et al. (2015)22

Germany

2008–2012

45/57.0

20/25

R, cohort/SC

ESBL-E

Huttner et al. (2019)29

Switzerland

2016–2017

39/65.0

18/21

P, case–control/MC

ESBL-E, CPE

Oren et al. (2013)16

Israel

2009–2011

152/55.6

90/62

P, case–control/SC

CRE

Fariñas (2021)17

Spain

2014–2018

105/56.7

76/29

P, case–control/MC

ESBL-E, CPE

Choi (2021)36

Korea

NS

13/67.9

2/8

P, case–control/SC

CRE

Ljungquist (2020)37

Sweden

2017–2019

80/68.0

29/51

P, case–control/SC

ESBL-E

Saïdani (2019)30

France

2015–2017

30/59.9

24/6

R, case–control/SC

CPE

Stoma (2018)18

Belarus

2016–2017

62/49

31/31

P, case–control/SC

CRGNB (included CRE)

Abecasis (2011)23

United Kingdom

2005–2006

39/NS

NS

P, cohort/SC

ESBL

Tascini (2014)24

Italy

NS

50/62.5

35/15

P, cohort/MC

KPC-Kp

Zuckerman (2011)25

Israel

2008–2009

15/55

7/8

P, cohort/SC

CRKP

Lübbert (2013)21

Germany

2010–2012

14/63

8/6

R, case–control/SC

KPC-Kp

Buehlmann (2011)26

Switzerland

2000–2008

100/NS

NS

P, cohort/SC

ESBL-E

Troché (2005)27

France

1995–2000

37/NS

NS

P, cohort/SC

ESBL-E

Davido (2017)35

France

2017

6/NS

4/2

P, cohort/MC

CRE

Nouvenne (2015)38

Italy

2011–2012

36/NS

NS

P, case–control/SC

CRKP

  1. NS not specified, R retrospective, P prospective, SC single center, MC multicenter, KP Klebsiella pnenmoniae, KA Klebsiella Aerogenes, CRE carbapenem-resistent Enterobacterales, CPE carbapenemase-producing Enterobacterales, CRGNB Carbapenem-resistant Gram-negative bacilli, ESBL-E extended-spectrumβ-lactam Enterobacterales, KPC-Kp KPC-producing Klebsiella pneumoniae, CRKP carbapenem-resistant Klebsiella pneumoniae.
Back to article page